Chameleon Communications International
Catherine Wood is a seasoned professional in the pharmaceutical and communications sectors, currently serving as a Senior Medical Writer at Chameleon Communications International since July 2020, after progressing through roles as Medical Writer and Associate Medical Writer. Prior to this, Catherine accumulated valuable experience at Eli Lilly and Company from July 2012 to May 2020 as a Senior Scientist. Earlier in their career, Catherine worked at Novartis in 2002-2003 as an Undergraduate Placement Student Laboratory Technician. Catherine holds an MPharmacol degree in Pharmacology from the University of Bath and a PhD in Neuroscience from the University of Bristol.
This person is not in any offices
Chameleon Communications International
Chameleon Communications has a 25 year heritage as a ground-breaking, entrepreneurial global medical communications agency partner. Driven by our philosophy to improve the lives of patients worldwide by positively changing the way medicine is practiced. People are our focus. We invest in and empower our people to provide the best talent in the industry. We build progressive internal collaborations and valued partnerships with our pharma clients to achieve the extraordinary together. We harness our collective (brain) power with 250+ experienced, dedicated experts across the globe, collaborating to bring inspiring intelligence to the development and execution of scientific and marketing communications. We are a member the Healthcare Consultancy Group (HCG) and part of Omnicom Health Group (OHG).
Industries
Employees
201-500